MedTrace Logo

Vision on the Road: Vision Rehabilitation for Driving After Stroke

NCT07147660 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2025-08-29

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if vision training works to improve functional vision in people with visual field loss after stroke. The investigators want to know more about how people perceive their own functional vision and ability to compensate for visual field loss in daily activities.

The main questions the study aims to answer are:

* Does vision training improve dimensions of functional vision?
* How does vision training affect the participants's perception of functional vision and the ability to compensate for visual field loss? Researchers will compare the effect of home-based vision training to standard care (no vision training) on functional vision.

Participants will:

* Participate in home-based vision training or standard care for 8 weeks
* Be contacted once a week by phone
* Keep a training diary

Conditions

  • Stroke
  • Visual Field Loss
  • Hemianopia

Interventions

OTHER

Compensatory scanning training

Individual home-based vision training exercises for 20 minutes every day for 8 weeks. A training program with online and manual oculomotor exercises, scanning and visual search-exercises. Weekly short follow up-conversation by telephone to check in and keep the motivation high with the participants.

OTHER

Delayed Compensatory scanning training

Delayed track start. Individual home-based vision training exercises for 20 minutes every day for 8 weeks. A training program with online and manual oculomotor exercises, scanning and visual search-exercises. Weekly short follow up-conversation by telephone to check in and keep the motivation high with the participants.

Sponsors & Collaborators

  • Lovisenberg Diakonale Hospital

    collaborator OTHER

  • University of South-Eastern Norway

    lead OTHER

Principal Investigators

  • Helle Falkenberg, Professor · University of South-Eastern Norway

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-28
Primary Completion
2027-12-31
Completion
2028-02-29

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07147660 on ClinicalTrials.gov